×
Uh Oh! It looks like you may have forgotten a required element in your template. Please review the
highlighted selections.
×
Some optional elements have been omitted. You can delete this from the synoptic if you don't want to include it.
Procedure (select all that apply)
Biopsy, shave
Biopsy, punch
Biopsy, incisional
Excision
Re-excision
Sentinel node(s) biopsy
Lymphadenectomy, regional nodes
Other
Not specified
Specimen Laterality
Right
Left
Midline
Not specified
Tumor Site
Tumor Size (mm, required only if tumor is grossly present)
Macroscopic Satellite Nodule(s)
Not identified
Present
Cannot be determined
Histologic Type
No residual melanoma identified
Superficial spreading melanoma
Nodular melanoma
Lentigo maligna melanoma
Acral lentiginous melanoma
Desmoplastic melanoma
Melanoma arising from blue nevus
Melanoma arising in a giant congenital nevus
Melanoma of childhood
Nevoid melanoma
Persistent melanoma
Melanoma, not otherwise classified
Superficial spreading Melanoma in situ
Melanoma in situ, lentigo maligna type
Acral-lentiginous Melanoma in situ
Melanoma in situ arising in a giant congenital nevus
Melanoma in situ of childhood
Persistent Melanoma in situ
Melanoma in situ, not otherwise classified
Other invasive histologic type not listed
Invasive tumor elements
Maximum Tumor (Breslow) Thickness (mm)
+ Anatomic (Clark) Level
At least level
II (melanoma present in but does not fill and expand papillary dermis)
III (melanoma fills and expands papillary dermis)
IV (melanoma invades reticular dermis)
V (melanoma invades subcutis)
Cannot be determined
Ulceration
Not identified
Present
Cannot be determined
Microsatellite(s)
Not identified
Present
Cannot be determined
Lymphovascular Invasion
Not identified
Present
Cannot be determined
Neurotropism
Not identified
Present
Cannot be determined
Mitotic Rate
+ Tumor-Infiltrating Lymphocytes
A word about TILs
Not identified
Present, nonbrisk
Present, brisk
Cannot be determined
Margins
Tumor Regression
Not identified
Present, involving less than 75% of lesion
Present, involving 75% or more of lesion
Cannot be determined
Regional Lymph Nodes
Pathologic Staging (pTNM)
TNM Descriptors (select all that apply)
Not applicable
m
r
y
pT
pT0: No evidence of primary tumor (eg, unknown primary or completely regressed melanoma)
pTis: Melanoma in situ (ie, not an invasive tumor: anatomic level I)
pT1a: Melanoma <0.8 mm in thickness, no ulceration
pT1b: Melanoma <0.8 mm in thickness with ulceration OR melanoma 0.8 to 1.0 mm in thickness with or without ulceration
pT2a: Melanoma >1.0 to 2.0 mm in thickness, no ulceration
pT2b: Melanoma >1.0 to 2.0 mm in thickness, with ulceration
pT3a: Melanoma >2.0 to 4.0 mm in thickness, no ulceration
pT3b: Melanoma >2.0 to 4.0 mm in thickness, with ulceration
pT4a: Melanoma >4.0 mm in thickness, no ulceration
pT4b: Melanoma >4.0 mm in thickness, with ulceration
pN
pNX: Regional lymph nodes not assessed (e.g., SLN biopsy not performed, regional nodes previously removed for another reason)
pN0: No regional lymph node metastasis detected
pN1a: One clinically occult tumor-involved node (ie, detected by sentinel node biopsy) with no in-transit, satellite and/or microsatellite metastases
pN1b: One clinically detected tumor-involved node with no in-transit, satellite and/or microsatellite metastases#
pN1c: Presence of in-transit, satellite and/or microsatellite metastases with no regional lymph node disease
pN2a: Two to three clinically occult tumor-involved node (ie, detected by sentinel node biopsy) with no in-transit, satellite and/or microsatellite metastases
pN2b: Two to three tumor-involved nodes at least one of which was clinically detected with no in-transit, satellite and/or microsatellite metastases#
pN2c: One clinically occult or clinically apparent tumor-involved node with presence of in-transit, satellite and/or microsatellite metastases
pN3a: Four or more clinically occult tumor-involved nodes (ie, detected by sentinel node biopsy) with no in-transit, satellite and/or microsatellite metastases
pN3b: Four or more tumor-involved nodes, at least one of which was clinically detected, with no in-transit, satellite and/or microsatellite metastases#
pN3c: Two or more clinically occult or clinically detected tumor-involved nodes with in-transit, satellite and/or microsatellite metastases and/or any number of matted nodes with in-transit, satellite and/or microsatellite metastases
pM
pMx: Not applicable
pM1a: Distant metastasis in skin, subcutaneous tissues, soft tissues including muscle and/or nonregional lymph nodes
pM1b: Distant metastasis to lung with or without M1a sites of disease
pM1c: Distant metastasis to non-CNS visceral sites with or without M1a or M1b sites of disease
pM1d: Distant metastasis to CNS with or without M1a, M1b or M1c sites of disease
Write Report
